Jeff Yass’s iBio IBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-412,725
| Closed | -$784K | – | 13905 |
|
|
2026
Q1 | $784K | Buy |
+412,725
| New | +$958K | ﹤0.01% | 8523 |
|
|
2025
Q4 | – | Sell |
-44,471
| Closed | -$36.8K | – | 12905 |
|
|
2025
Q3 | $36.8K | Buy |
+44,471
| New | +$34.2K | ﹤0.01% | 11938 |
|
|
2025
Q2 | – | Sell |
-32,413
| Closed | -$130K | – | 13131 |
|
|
2025
Q1 | $130K | Buy |
+32,413
| New | +$126K | ﹤0.01% | 11334 |
|
|
2023
Q4 | – | Sell |
-788
| Closed | -$3.44K | – | 12763 |
|
|
2023
Q3 | $4.78K | Buy |
+788
| New | +$6.81K | ﹤0.01% | 11794 |
|
|
2023
Q1 | – | Sell |
-6,742
| Closed | -$173K | – | 12979 |
|
|
2022
Q4 | $59.9K | Buy |
6,742
+5,606
| +493% | +$190K | ﹤0.01% | 11292 |
|
|
2022
Q3 | $97K | Buy |
1,136
+39
| +4% | +$5.37K | ﹤0.01% | 11733 |
|
|
2022
Q2 | $145K | Buy |
1,097
+597
| +119% | +$89.7K | ﹤0.01% | 11066 |
|
|
2022
Q1 | $107K | Sell |
500
-1,865
| -79% | -$390K | ﹤0.01% | 11859 |
|
|
2021
Q4 | $649K | Buy |
2,365
+133
| +6% | +$50.7K | ﹤0.01% | 8458 |
|
|
2021
Q3 | $1.18M | Sell |
2,232
-523
| -19% | -$326K | ﹤0.01% | 7119 |
|
|
2021
Q2 | $2.08M | Sell |
2,755
-236
| -8% | -$172K | ﹤0.01% | 5831 |
|
|
2021
Q1 | $2.3M | Buy |
2,991
+853
| +40% | +$743K | ﹤0.01% | 5582 |
|
|
2020
Q4 | $1.12M | Buy |
2,138
+859
| +67% | +$700K | ﹤0.01% | 6452 |
|
|
2020
Q3 | $1.3M | Buy |
+1,279
| New | +$1.85M | ﹤0.01% | 5498 |
|
|
2020
Q2 | – | Sell |
-173
| Closed | -$92K | – | 10463 |
|
|
2020
Q1 | $92K | Buy |
+173
| New | +$66.6K | ﹤0.01% | 9376 |
|
|
2018
Q2 | – | Sell |
-10
| Closed | -$11K | – | 9938 |
|
|
2018
Q1 | $11K | Buy |
+10
| New | +$10.5K | ﹤0.01% | 9177 |
|
|
2017
Q4 | – | Sell |
-19
| Closed | -$31K | – | 9533 |
|
|
2017
Q3 | $31K | Buy |
19
+10
| +111% | +$16.1K | ﹤0.01% | 8611 |
|
|
2017
Q2 | $18K | Buy |
+9
| New | +$17.6K | ﹤0.01% | 9033 |
|
|
2016
Q2 | – | Sell |
-3
| Closed | -$9K | – | 8872 |
|
|
2016
Q1 | $9K | Buy |
+3
| New | +$8.6K | ﹤0.01% | 8885 |
|
|
2015
Q1 | – | Sell |
-3
| Closed | -$9K | – | 9622 |
|
|
2014
Q4 | $9K | Buy |
+3
| New | +$16K | ﹤0.01% | 9523 |
|
Other funds holding IBIO
AAA
CAM
SCM
VPC
FLSM
WP
Jeff Yass's IBIO Position: Q2 2026 in Review
Jeff Yass sold out of iBio (IBIO) in Q2 2026, closing a stake of 412,725 shares — an estimated $784K sold.
Jeff Yass first reported a position in IBIO in Q4 2014 and held it in 20 quarters. The position peaked at $2.3M in Q1 2021. 55 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.
- Jeff Yass reported no remaining iBio position as of Q2 2026 after selling out during the quarter.
- Jeff Yass sold 412,725 iBio shares in Q2 2026, an estimated $784K.
- Jeff Yass first reported a position in iBio in Q4 2014 and held it in 20 quarters.
- Jeff Yass's iBio position peaked at $2.3M in Q1 2021.
- 55 funds tracked by Wall St. Rank held iBio as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.